Scarica l'app Stockscreener
10.14
0.05%
0.005
Precedente Chiudi:
$10.14
Aprire:
$10.16
Volume 24 ore:
118.58K
Relative Volume:
31.12
Capitalizzazione di mercato:
$565.08M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-5.3677
EPS:
-1.89
Flusso di cassa netto:
-
1 W Prestazione:
-0.15%
1M Prestazione:
-0.44%
6M Prestazione:
-80.49%
1 anno Prestazione:
-80.49%
Intervallo 1D:
$10.14
$10.16
Intervallo di 1 settimana:
$10.14
$10.16
Portata 52W:
$10.07
$10.45
Churchill Capital Corp Xi Stock (CCXI) Company Profile
Nome
Churchill Capital Corp Xi
Settore
Industria
Telefono
-
Indirizzo
-
Compare CCXI vs LION, XXI, UMAC, DMII, BCSS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CCXI
Churchill Capital Corp Xi
|
10.14 | 565.08M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
9.72 | 2.82B | 2.80B | -224.60M | -1.10M | -0.8751 |
|
XXI
Twenty One Capital Inc
|
6.82 | 2.36B | 0 | 4.35M | 456.40K | 0.3397 |
|
UMAC
Unusual Machines Inc
|
20.40 | 777.44M | 0 | -5.28M | -3.11M | -0.6947 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.95 | 652.47M | 0 | 0 | 0 | -0.0028 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.13 | 591.59M | 0 | 0 | 0 | 0.00 |
Churchill Capital Corp Xi Stock (CCXI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-11 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-10-11 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-10-08 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-10-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-07-07 | Aggiornamento | Stifel | Hold → Buy |
| 2021-05-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-05-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-05-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-05-07 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-05-07 | Downgrade | Stifel | Buy → Hold |
| 2021-03-02 | Reiterato | H.C. Wainwright | Buy |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2020-10-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-05-27 | Iniziato | Wells Fargo | Overweight |
| 2020-05-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-24 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-26 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-26 | Reiterato | Piper Jaffray | Overweight |
| 2019-03-27 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2019-02-11 | Iniziato | Piper Jaffray | Overweight |
| 2018-09-07 | Iniziato | B. Riley FBR | Neutral |
| 2018-08-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-06-28 | Iniziato | Raymond James | Strong Buy |
| 2018-05-02 | Iniziato | H.C. Wainwright | Buy |
| 2017-02-21 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-05-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2013-05-20 | Reiterato | Stifel | Buy |
| 2012-11-14 | Iniziato | Stifel Nicolaus | Buy |
Mostra tutto
Churchill Capital Corp Xi Borsa (CCXI) Ultime notizie
Free float of Churchill Capital Corp XI – NASDAQ:CCXIW - TradingView
Art Technology Acquisition Corp.: Performance & Quotes, ARTC Stock Price on Nasdaq Exchange - marketscreener.com
SPACSphere Acquisition Corp.: Performance & Quotes, SSAC Stock Price on Nasdaq Exchange - marketscreener.com
Soren Acquisition Corp.: Performance & Quotes, SORN Stock Price on Nasdaq Exchange - marketscreener.com
CCXI Technical Analysis & Stock Price Forecast - Intellectia AI
MML Acquisition Stock (MML.H)Quote Toronto S.E. - marketscreener.com
MML Acquisition: Dividend historical data and projections - marketscreener.com
White Pearl Acquisition Corp.: Performance & Quotes, WPAC Stock Price on Nyse Exchange - marketscreener.com
Eagle Nuclear Energy Corp.: Dividend historical data and projections - marketscreener.com
Eagle Nuclear Energy Corp.: Shareholders Board Members Managers and Company Profile | US2697101093 - marketscreener.com
Eagle Nuclear Energy Corp.: Performance & Quotes, NUCL Stock Price on Nasdaq Exchange - marketscreener.com
Mountain Lake Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Lake Superior Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Free float of Churchill Capital Corp XI – BOATS:CCXIW - TradingView
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
MML Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Churchill Capital Corp XIUnits (NQ: CCXIU - The Chronicle-Journal
Trailblazer Holdings, Inc.: Dividend historical data and projections - marketscreener.com
Magnetar Financial LLC Acquires 2,700,000 Shares in Churchill Ca - GuruFocus
DermTech Stock (DMTK)Quote OTC Markets - marketscreener.com
CCXIW Stock Price, News & Analysis - Stock Titan
Churchill Capital Corp XI(NasdaqGM: CCXI) added to NASDAQ Composite Index - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Churchill Capital’s 47% plunge validates InvestingPro’s overvaluation alert By Investing.com - Investing.com Australia
Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026 - The Manila Times
Churchill Capital Corp XI Announces Separate Trading of Shares and Warrants - TradingView
US FDA Review Team Split On Amgen’s Tavneos Years Before Withdrawal Request - Citeline News & Insights
Asking Amgen to withdraw Tavneos, FDA revisits years-old data issue - BioCentury
Amgen thumbs-down on FDA’s ask, Tavneos sales continue - BioWorld MedTech
Amgen resists FDA request to pull rare disease drug Tavneos from the market - Fierce Pharma
Amgen’s Revenue Gains Outweigh News That FDA Wants Tavneos Pulled From Market - Citeline News & Insights
Amgen Defends Tavneos Benefit-Risk Profile Following FDA Withdrawal Request - Medical Professionals Reference
US FDA Wants Tavneos Pulled From Market, Amgen Declines - Citeline News & Insights
EMA reviewing Amgen’s vasculitis drug over trial ‘data integrity’ - BioWorld MedTech
Horizon (HRZN) and Monroe Capital (MRCC) outline proxy drive for proposed merger and asset sale - Stock Titan
1 km lidar partnership for safer cars, trains and transport systems - Stock Titan
Rough Price Target for a Promising Quantum Computing Name Working With Nvidia - TheStreet Pro
CCCXChurchill Cap Corp X Latest Stock News & Market Updates - Stock Titan
Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next - TechStock²
Churchill Capital Corp XI completes $414 million IPO and private placement - Investing.com
Infleqtion Chief Scientist for Quantum Information Dr. Mark Saffman Awarded the John Stewart Bell Prize - 01net
U.S. IPO Weekly Recap: Medline Headlined Final Week Before Christmas - Seeking Alpha
Churchill Capital Corp XI completes $414 million IPO on NASDAQ - Investing.com Nigeria
Churchill Capital Corp XI Announces the Pricing of Upsized $360 Million Initial Public Offering - Yahoo Finance
Another SPAC Boom is Coming; And It’s Stronger than Ever - themiddlemarket.com
Deal Watch: Skadden, Davis Polk, Wachtell, Cravath Lead $20B Deals, as Mega M&A Continues - Law.com
IPO NewsUS IPO Weekly Recap: 2 IPOs come to market, pipeline grows ahead of Thanksgiving holiday week - renaissancecapital.com
3 Firms Lead Churchill Capital's Latest $300M SPAC Filing - Law360
Canaan (NASDAQ: CAN) closes $72M registered direct offering; ADSs at $1.131 - Stock Titan
Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. - Newsfile
Anca Vasculitis Drug Market Set for Dynamic Rise with Key Players ChemoCentryx, Inc. and Vifor Pharma - openPR.com
Churchill Capital Corp Xi Azioni (CCXI) Dati Finanziari
Non sono disponibili dati finanziari per Churchill Capital Corp Xi (CCXI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.45%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):